Literature DB >> 9643347

Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model.

B Lamarche1, K D Uffelman, G Steiner, P H Barrett, G F Lewis.   

Abstract

Hypertriglyceridemia is commonly associated with triglyceride (TG) enrichment of high density lipoprotein (HDL) and reduction in HDL cholesterol and apolipoprotein A-I levels. We have recently reported that lipolytic modification of TG-rich HDL, which reduces particle size, enhances its clearance from the circulation. In the present study, we examined the role of particle size and lipid composition in determining the metabolic clearance of human HDL, in the absence of substantial in vivo modification of the particle by hepatic lipase. The rabbit, which has a very low hepatic lipase activity, was used for this purpose. Plasma fractions d < 1.21 g/ml were first isolated by ultracentrifugation from fasting humans with normal (NTG, n=6, mean plasma TG concentration=1.26+/-0.21 (SEM) mmol/l) or elevated plasma TG levels (HTG, n=5, TG=4.49+/-0.65 mmol/l). Small and large HDL particles were separated by gel filtration chromatography and were labeled with either 125I or (131)I. Large HDL were cleared more rapidly than small HDL in 10 out of 11 studies (P=0.006). There was, however, no difference in the fractional catabolic rate (FCR) of large HDL isolated from NTG versus from HTG subjects or in the FCR of small HDL from NTG versus HTG individuals. There was also no correlation between the TG content of HDL and its FCR. In summary, large, lipid-rich human high density lipoproteins (HDL) are cleared more rapidly than small human HDL in rabbits. These results, combined with our previous observation, also support the hypothesis that triglyceride enrichment of HDL, in the absence of substantial lipolytic modification, is not sufficient to enhance its clearance from the circulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9643347

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  5 in total

1.  Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

Authors:  B Lamarche; K D Uffelman; A Carpentier; J S Cohn; G Steiner; P H Barrett; G F Lewis
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  Increased HDL Size and Enhanced Apo A-I Catabolic Rates Are Associated With Doxorubicin-Induced Proteinuria in New Zealand White Rabbits.

Authors:  Victoria López-Olmos; Elizabeth Carreón-Torres; María Luna-Luna; Cristobal Flores-Castillo; Miriam Martínez-Ramírez; Rocío Bautista-Pérez; Martha Franco; Julio Sandoval-Zárate; Francisco-Javier Roldán; Alberto Aranda-Fraustro; Elizabeth Soria-Castro; Mónica Muñoz-Vega; José-Manuel Fragoso; Gilberto Vargas-Alarcón; Oscar Pérez-Méndez
Journal:  Lipids       Date:  2016-01-19       Impact factor: 1.880

3.  Effect of weight loss, independent of change in diet composition, on apolipoprotein AI kinetic in men with metabolic syndrome.

Authors:  Caroline Richard; Patrick Couture; Sophie Desroches; Alice H Lichtenstein; Benoît Lamarche
Journal:  J Lipid Res       Date:  2012-11-02       Impact factor: 5.922

4.  Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma.

Authors:  M A Rajora; L Ding; M Valic; W Jiang; M Overchuk; J Chen; G Zheng
Journal:  Chem Sci       Date:  2017-05-23       Impact factor: 9.825

Review 5.  Advances in HDL: Much More than Lipid Transporters.

Authors:  Soumaya Ben-Aicha; Lina Badimon; Gemma Vilahur
Journal:  Int J Mol Sci       Date:  2020-01-22       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.